https://clinicaltrials.gov/ct2/show/NCT03393013?type=Intr&cond=Lupus&phase=012345&lupd_s=03%2F12%2F2019&lupd_d=14
Conditions : Systemic Lupus Erythematosus; Lupus Nephritis
Interventions : Drug: KZR-616; Drug: Placebo
Sponsor : Kezar Life Sciences, Inc.
Recruiting
A Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis
NCT03393013
Mon, 08 Jan 2018 12:00:00 EST
